RORα inhibits gastric cancer proliferation through attenuating G6PD and PFKFB3 induced glycolytic activity.

Authors:
Wang X; Zhang J; Wu Y; Zhang Y; Zhang S and 3 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-023-03201-4

PMCID:
PMC10770990

PMID:
38184549

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"additional file 2 : fig s2). fig 5 ror? n = 3. all data"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was carried out following the World Medical Association’s Declaration of Helsinki and was approved by the Research Ethics Committee in The First Affiliated of Anhui Medical University. Written informed consent was obtained from all participants. Consent for publicationThis paper has not been published or accepted for publication. It is not under consideration at another journal. The publications were approved by all authors. Competing interestsThe authors declares that there no conflicts of interest. Competing interests The authors declares that there no conflicts of interest."

Evidence found in paper:

"Funding This study was funded by natural science foundation of Anhui province (grant no. 2008085MH1294)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025